Shenzhen, Guangdong, China In 2008 was created South China Venture Capital, which is appeared as VC. The main office of represented VC is situated in the Shenzhen. The fund was located in Asia if to be more exact in China.
The top activity for fund was in 2019. The fund is constantly included in 2-6 investment rounds annually. Considering the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of 50 - 100 millions dollars.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the South China Venture Capital, startups are often financed by Trend Investment Group, Oriza Seed Capital (Oriza Yuandian), OrbiMed. The meaningful sponsors for the fund in investment in the same round are Sherpa Venture Capital, Shenzhen Capital Group, SDIC Fund Management.
The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Apollomics, EpimAb Biotherapeutics, Ipoweru.cn. We can highlight the next thriving fund investment areas, such as Training, Health Care. For fund there is a match between the location of its establishment and the land of its numerous investments - China. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
Related Funds
Funds with similar focus
| Fund Name | Location |
| All Turtles | California, San Francisco, United States |
| Beijing Zhidian Touzi Co., Ltd. | Beijing, Beijing, China |
| Bravio Capital | - |
| C.M. Capital Corporation | California, Palo Alto, United States |
| eLab Technology Fund | Canada, Ontario, Toronto |
| Equentia Natural Resources | - |
| F1 Solutions | - |
| Huanqiu Zhongcheng Zichan | Beijing, China, Haidian |
| Karmel Capital | California, United States, Vista |
| KSVFinland | - |
| Madison Securities | - |
| Miura Co.,Ltd. | Ehime Prefecture, Japan, Matsuyama |
| Niche Capital | Lagos, Lagos, Nigeria |
| Novus Energy | Minneapolis, Minnesota, United States |
| Oracle Strategic Partners | Connecticut, Greenwich, United States |
| PGGM Investments | The Netherlands, Utrecht, Zeist |
| Shanghai Guang Nuoyuan Chuangtou | Beijing, Beijing, China |
| Twenty3 Capital | - |
| Zhichen Investment | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Yuewei Medical | $15M | 28 Dec 2023 | Beijing, Beijing, China | ||
Presheng | 14 Dec 2023 | - | |||
Sanhydro Technology | 10 Nov 2023 | Changzhou, Zhejiang, China | |||
Namei Semiconductor | 31 Oct 2023 | Guangzhou, Guangdong, China | |||
Zentek | 25 Oct 2023 | Zhangjiagang, Jiangsu, China | |||
Avant Semi | $15M | 07 Jul 2023 | Pudong, Shandong, China | ||
Huixin Bio | 19 Jan 2023 | Shenzhen, Guangdong, China | |||
Zheta Technology | $13M | 21 Nov 2022 | Hefei, Anhui, China | ||
Bangxin Semiconductor | 01 Jun 2022 | Shanghai, Shanghai, China |
– Cullgen Inc. closed a $50m Series B financing (assuming exercise of warrant).
– The round was led by 3E Bioventures Capital, as well as Heights Capital Management (an affiliate of Susquehanna International Group), Octagon Capital, MSA Capital and South China Venture Capital.
– The financing will support the development of Cullgen’s technology platform and internal pipeline of targeted protein degraders in oncology and other diseases.
– Frank Yan, from 3E Bioventures, will be joining Cullgen’s board of directors.
– Cullgen is also pleased to announce that Frank Yan, from 3E Bioventures, will be joining Cullgen’s board of directors.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Yuewei Medical | $15M | 28 Dec 2023 | Beijing, Beijing, China | ||
Presheng | 14 Dec 2023 | - | |||
Sanhydro Technology | 10 Nov 2023 | Changzhou, Zhejiang, China | |||
Namei Semiconductor | 31 Oct 2023 | Guangzhou, Guangdong, China | |||
Zentek | 25 Oct 2023 | Zhangjiagang, Jiangsu, China | |||
Avant Semi | $15M | 07 Jul 2023 | Pudong, Shandong, China | ||
Huixin Bio | 19 Jan 2023 | Shenzhen, Guangdong, China | |||
Zheta Technology | $13M | 21 Nov 2022 | Hefei, Anhui, China | ||
Bangxin Semiconductor | 01 Jun 2022 | Shanghai, Shanghai, China |
